This week in charts: Moderna’s massive stock run
BioPharma DiveDelilah AlvaradoOctober 16, 2026
The latest installment in BioPharma Dive s data visualization-focused series includes a look at Moderna s meteoric rise in 2026 and a sudden deal surge from Roche.